Ultra-processed food (UPF) intake in pregnancy and maternal and neonatal outcomes
European Journal of Nutrition · 2023
DOI: 10.1007/s00394-022-03072-x ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nutrition, 2023. Verfasst von Sivan Ben-Avraham und 6 weiteren Autor:innen. Beteiligte Einrichtung: The International Center for Health Innovation & Nutrition, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, …. Hauptthemen laut MEDLINE: Food, Processed, Food Handling. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Environment and Health Fund.
Abstract (Originalsprache)
PURPOSE: Ultra-processed food (UPF), as defined by the NOVA classification, is related to lower diet quality, which may adversely affect maternal health and neonatal outcomes. This study aims to describe nutrient intake of pregnant women by the share of UPF in the diet and to identify associations between UPF intake and maternal and neonatal outcomes. METHODS: In this cross-sectional study, pregnant women (n = 206) were recruited upon arrival to the obstetrics ward for delivery, and asked to complete a Food Frequency Questionnaire (FFQ), and questionnaires regarding environmental exposures, and socio-demographic characteristics. Neonatal measurements and clinical data were obtained following delivery. UPF energy intake was expressed as absolute and in terms of percent from total energy. Women with high intake of energy from UPF were compared to those with low intake. RESULTS: Among 206 pregnant women, dietary intake of UPF ranged from 15.6% to 43.4% of total energy in the first and fourth quartiles of UPF consumption, respectively. Women in the fourth quartile of energy from UPF had lower intakes of vitamin C, beta-carotene, vitamin B6, and potassium, which is indicative of inferior diet quality. Percent energy from UPF was associated with maternal obesity (BMI ≥ 30) (OR = 1.06, 95% CI: 1.06, 1.10, p = 0.008) and shorter male infant ano-genital distance (AGD) (B = -1.9, 95% CI: -3.5, -0.24, p = 0.02). CONCLUSIONS: UPF intake during pregnancy is associated with undesirable maternal and neonatal outcomes and more research is needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The International Center for Health Innovation & Nutrition, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva, Israel.
- Clinical Pharmacology and Toxicology Unit, Shamir (Assaf Harofeh) Medical Center, Zerifin, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- The Department of Nutritional Sciences, Tel Hai College, Upper Galilee 9977, 1220800, Qiryat Shmona, Israel.
- Departments of Neonatology and Pediatrics, Dana Dwek Children's Hospital, Tel-Aviv Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
- The International Center for Health Innovation & Nutrition, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva, Israel. dshahar@bgu.ac.il.
Förderung
- Environment and Health Fund
Zitieren
APA
Ben-Avraham, S., Kohn, E., Tepper, S., Lubetzky, R., Mandel, D., Berkovitch, M., & Shahar, D. R. (2023). Ultra-processed food (UPF) intake in pregnancy and maternal and neonatal outcomes. European Journal of Nutrition. https://doi.org/10.1007/s00394-022-03072-x
Vancouver
Ben-Avraham S, Kohn E, Tepper S, Lubetzky R, Mandel D, Berkovitch M, et al. Ultra-processed food (UPF) intake in pregnancy and maternal and neonatal outcomes. European Journal of Nutrition. 2023. doi:10.1007/s00394-022-03072-x
BibTeX
@article{BenAvraham2023,
author = {Ben-Avraham, Sivan and Kohn, Elkana and Tepper, Sigal and Lubetzky, Ronit and Mandel, Dror and Berkovitch, Matitiahu and Shahar, Danit R},
title = {Ultra-processed food (UPF) intake in pregnancy and maternal and neonatal outcomes},
journal = {European Journal of Nutrition},
year = {2023},
doi = {10.1007/s00394-022-03072-x}
}
EUVIMED